Rare diseases
Investigational molecules
Locations
A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema
ItalyStudy of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments
ItalyStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
ItalyStudy of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer
ItalyStudy of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer
ItalyStudy comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy
ItalyStudy of pembrolizumab and lenvatinib treatment for patients with vulvar cancer
ItalyStudy of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer
ItalyStudy of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems
ItalyStudy comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients
ItalyStudy of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment
ItalyStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
